Published in Women's Health Weekly, January 12th, 2006
According to recent research from England, "There is an unmet need to develop imaging methods for the early and objective assessment of breast tumors to therapy. [F-18]FLT-positron emission tomography represents a new approach to imaging thymidine kinase activity, and hence, cellular proliferation. We compare graphical, spectral, and semiquantitative analytic methodologies for quantifying [F-18]FLT kinetics in tumor and normal tissue of patients with locally advanced and metastatic breast cancer."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly